Michelle Marks, DO
Pediatric Hospital Medicine
Highlights
Age Groups Seen
- Child
- Adolescent
Languages
- English
Gender
FemaleAbout Michelle Marks
Title
Medical Director
Biography
Michelle Marks, DO, FAAP, SFHM is a Staff physician in the Department of Pediatric Hospital Medicine at Cleveland Clinic Children's Hospital and Vice-Chair of the Pediatric Institute, Medical Director, Cleveland Clinic Children's Hospital for Rehabilitation.
Dr. Marks earned a doctor of osteopathic medicine at Ohio University College of Osteopathic Medicine and completed a pediatric internship at Doctor’s Hospital in Columbus, Ohio before coming to Cleveland Clinic for her residency where she served as chief pediatric resident. Board-certified by the American Board of Pediatrics in General Pediatrics and Pediatric Hospital Medicine. Dr. Marks is licensed to practice medicine in Ohio.
Listed in the 2006- 2019 edition of “Best Doctors in America,” Dr. Marks won a “Distinguished Teaching” award from the Division of Pediatrics and the Taylor Koose Compassionate Care award. She is a member of the American Academy of Pediatrics and the Society for Hospital Medicine.
Locations
- Cleveland Clinic Children's Hospital for Rehabilitation
- 2801 Martin Luther King Jr Drive, Cleveland, OH 44104
- Get Directions
Education & Board Certifications
Education
- Residency: Cleveland Clinic, 1996
- Internship: Doctors Hospital, 1993
- Medical Education: Ohio University College of Osteopathic Medicine, 1992
- Undergraduate: University of Toledo, 1988
Board Certifications
- Pediatric Hospital Medicine: American Board of Pediatrics, 2019
- Pediatrics: American Board of Pediatrics, 1996
Awards
Professional Memberships
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-03-20, Dr. Marks has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.